Other OTC - Delayed Quote • USD
Navidea Biopharmaceuticals, Inc. (NAVB)
At close: April 18 at 3:22 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0.6100
14.6450
45.6150
118.7250
Cost of Revenue
50.0360
184.9470
--
1.0480
Gross Profit
-49.4260
-170.3020
45.6150
117.6770
Operating Expense
10,130.1990
13,880.5930
12,106.0270
10,828.8580
Operating Income
-10,179.6250
-14,050.8950
-12,060.4120
-10,711.1810
Net Non Operating Interest Income Expense
3.0510
-1,098.3220
-6.3610
11.3440
Other Income Expense
1,569.4530
-27.9390
351.8850
-21.8540
Pretax Income
-8,607.1210
-15,177.1560
-11,714.8880
-10,721.6910
Tax Provision
--
--
16.0430
--
Net Income Common Stockholders
-1,389.4620
-17,215.0390
-11,730.9270
-11,385.5800
Diluted NI Available to Com Stockholders
-1,389.4620
-17,215.0390
-11,730.9270
-11,385.5800
Basic EPS
-0.08
-0.56
-0.40
-0.48
Diluted EPS
-0.08
-0.56
-0.40
-0.48
Basic Average Shares
53,346.7490
30,901.8690
29,343.5420
23,896.0010
Diluted Average Shares
53,346.7490
30,901.8690
29,343.5420
23,896.0010
Total Operating Income as Reported
-10,179.6250
-14,050.8950
-12,060.4120
-10,711.1810
Total Expenses
10,180.2350
14,065.5400
12,106.0270
10,829.9060
Net Income from Continuing & Discontinued Operation
-1,182.4800
-15,177.1530
-11,730.9270
-10,721.6910
Normalized Income
-9,172.4240
-15,177.1530
-11,998.1070
-10,721.6910
Interest Income
--
--
--
11.3440
Interest Expense
--
1,098.3220
6.3610
--
Net Interest Income
3.0510
-1,098.3220
-6.3610
11.3440
EBIT
-10,207.5640
-14,078.8340
-11,708.5270
-10,711.1810
EBITDA
-10,099.3800
-13,983.0150
-11,631.5730
-10,640.7880
Reconciled Cost of Revenue
50.0360
184.9470
--
1.0480
Reconciled Depreciation
108.1840
95.8190
76.9540
70.3930
Net Income from Continuing Operation Net Minority Interest
-8,607.4800
-15,177.1530
-11,730.9270
-10,721.6910
Total Unusual Items Excluding Goodwill
564.9440
--
366.0000
--
Total Unusual Items
564.9440
--
366.0000
--
Normalized EBITDA
-10,664.3240
-13,983.0150
-11,997.5730
-10,640.7880
Tax Rate for Calcs
--
--
0.0003
--
Tax Effect of Unusual Items
--
--
98.8200
--
12/31/2020 - 11/10/1992
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
WINT Windtree Therapeutics, Inc.
0.3398
-14.21%
IPIX Innovation Pharmaceuticals Inc.
0.0101
+1.00%
CNBX CNBX Pharmaceuticals Inc.
0.0104
-15.10%
EVLO Evelo Biosciences, Inc.
0.0500
+13.77%
CDMO Avid Bioservices, Inc.
6.52
-2.83%
TVGN Tevogen Bio Holdings Inc.
2.1200
-7.22%
CINGW Cingulate Inc.
0.0150
+29.31%
RDPTF Radiopharm Theranostics Limited
0.0008
0.00%
SIGY Sigyn Therapeutics, Inc.
5.50
-9.84%
XTLB.TA XTL Biopharmaceuticals Ltd.
9.00
-1.10%